PKMYT1(蛋白激酶膜相关酪氨酸/苏氨酸1),是丝氨酸/苏氨酸激酶WEE家族的成员,磷酸化细胞周期蛋白依赖性激酶1(CDK1)的苏氨酸14(Thr14),这抑制了它(与细胞周期蛋白B复合时)触发有丝分裂的能力。查看全文
苏泽逸2023-05-22 12:51
$Repare(RPTX)$ 一家开发新型合成致死靶向疗法的精准肿瘤学公司。类似国内南京英派药业。(君实生物是英派药业股东之一)
prepare的平台利用了专有的高通量CRISPR基因编辑方法来发现靶点,同时也结合高分辨率蛋白质晶体学,计算机生物学和临床信息学。查看全文
Repare(RPTX)03-28 07:05
$Repare(RPTX)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001415889-24-009253 Size: 9 KB 网页链接查看全文
Repare(RPTX)03-28 07:05
$Repare(RPTX)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001415889-24-009251 Size: 9 KB 网页链接查看全文
Repare(RPTX)03-28 07:05
$Repare(RPTX)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001415889-24-009249 Size: 10 KB 网页链接查看全文
Repare(RPTX)03-28 07:05
$Repare(RPTX)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001415889-24-009255 Size: 9 KB 网页链接查看全文
Repare(RPTX)03-27 02:55
$Repare(RPTX)$ 144 Report of proposed sale of securities Accession Number: 0001976873-24-000001 Act: 33 Size: 336 KB 网页链接查看全文
Repare(RPTX)03-26 04:25
$Repare(RPTX)$ 144 Report of proposed sale of securities Accession Number: 0001950047-24-002689 Act: 33 Size: 4 KB 网页链接查看全文
格隆汇6月2日丨Repare Therapeutics盘前大涨逾19%,报10.42美元。6月1日,Repare Therapeutics宣布,已与罗氏就camonsertib(RP-3500)的开发和商业化达成全球许可和合作协议。根据协议,罗氏将承担camonsertib的开发,并有可能将开发扩展到其他肿瘤和多种... 网页链接
$Repare(RPTX)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001415889-24-009249 Size: 10 KB 网页链接
$Repare(RPTX)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001415889-24-009251 Size: 9 KB 网页链接
$Repare(RPTX)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001415889-24-009253 Size: 9 KB 网页链接
$Repare(RPTX)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001415889-24-009255 Size: 9 KB 网页链接
$Repare(RPTX)$ 144 Report of proposed sale of securities Accession Number: 0001976873-24-000002 Act: 33 Size: 322 KB 网页链接
$Repare(RPTX)$ 144 Report of proposed sale of securities Accession Number: 0001976873-24-000001 Act: 33 Size: 336 KB 网页链接
$Repare(RPTX)$ 144 Report of proposed sale of securities Accession Number: 0001231919-24-000040 Act: 33 Size: 4 KB 网页链接
$Repare(RPTX)$ 144 Report of proposed sale of securities Accession Number: 0001950047-24-002688 Act: 33 Size: 4 KB 网页链接
$Repare(RPTX)$ 144 Report of proposed sale of securities Accession Number: 0001950047-24-002689 Act: 33 Size: 4 KB 网页链接
$Repare(RPTX)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001415889-24-006590 Size: 7 KB 网页链接